{"product_id":"pure-eloralintide-10mg-selective-amylin-research-peptide","title":"Pure Eloralintide 10mg | Selective Amylin Research Peptide","description":"\u003ch3 data-section-id=\"n3c97h\" dir=\"auto\" data-start=\"1305\" data-end=\"1331\" class=\"PDq2pG_selectionAnchorContainer\"\u003ePure Eloralintide 10mg\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp dir=\"auto\" data-start=\"1333\" data-end=\"1400\"\u003e\u003cstrong data-start=\"1333\" data-end=\"1400\"\u003eResearch Grade • 10mg Reference Strength • Third-Party Verified\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" data-start=\"1402\" data-end=\"1615\"\u003ePure Eloralintide 10mg is a research-grade peptide containing \u003cstrong data-start=\"1464\" data-end=\"1492\"\u003eeloralintide (LY3841136)\u003c\/strong\u003e, an investigational long-acting selective amylin receptor agonist being studied in metabolic and obesity-related research.\u003c\/p\u003e\n\u003cp dir=\"auto\" data-start=\"1617\" data-end=\"1873\"\u003eEloralintide is designed to preferentially activate the \u003cstrong data-start=\"1673\" data-end=\"1702\"\u003eamylin 1 receptor (AMY1R)\u003c\/strong\u003e, providing researchers with a distinct pathway for investigating appetite, satiety, food-intake regulation and metabolic signalling. \u003cspan class=\"contents\" data-content-reference-start=\"1842\" data-content-reference-end=\"1874\"\u003e\u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 data-section-id=\"15v820j\" dir=\"auto\" data-start=\"1875\" data-end=\"1893\"\u003eResearch Focus\u003c\/h3\u003e\n\u003cp dir=\"auto\" data-start=\"1895\" data-end=\"1986\"\u003eEloralintide is currently being investigated across clinical research programmes examining:\u003c\/p\u003e\n\u003cul data-start=\"1988\" data-end=\"2224\"\u003e\n\u003cli data-section-id=\"wrqebw\" data-start=\"1988\" data-end=\"2016\"\u003eAmylin receptor signalling\u003c\/li\u003e\n\u003cli data-section-id=\"9d455p\" data-start=\"2017\" data-end=\"2048\"\u003eAppetite and satiety pathways\u003c\/li\u003e\n\u003cli data-section-id=\"1oivqq7\" data-start=\"2049\" data-end=\"2073\"\u003eFood-intake regulation\u003c\/li\u003e\n\u003cli data-section-id=\"r5h5xo\" data-start=\"2074\" data-end=\"2096\"\u003eBody-weight research\u003c\/li\u003e\n\u003cli data-section-id=\"1qxzlwn\" data-start=\"2097\" data-end=\"2117\"\u003eMetabolic research\u003c\/li\u003e\n\u003cli data-section-id=\"tc4qzw\" data-start=\"2118\" data-end=\"2144\"\u003eObesity-related research\u003c\/li\u003e\n\u003cli data-section-id=\"1cbxksk\" data-start=\"2145\" data-end=\"2197\"\u003eCombination approaches involving incretin pathways\u003c\/li\u003e\n\u003cli data-section-id=\"14x05md\" data-start=\"2198\" data-end=\"2224\"\u003eCardiometabolic research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\" data-start=\"2226\" data-end=\"2546\"\u003eCurrent clinical development includes Phase 3 studies evaluating eloralintide in different obesity and overweight research populations, including studies involving type 2 diabetes, obstructive sleep apnea, osteoarthritis and combination therapy with weekly incretin-based treatment.\u003c\/p\u003e","brand":"Pure Performance Labs","offers":[{"title":"Default Title","offer_id":50673265836257,"sku":null,"price":2399.0,"currency_code":"ZAR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0825\/1935\/9713\/files\/PureEloralintide_f3059c03-0586-4367-85b3-7dbe16ff08cc.png?v=1790929899","url":"https:\/\/health-tech.co.za\/products\/pure-eloralintide-10mg-selective-amylin-research-peptide","provider":"Health Tech","version":"1.0","type":"link"}